• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / NEWS . . . . . . . . / Science & Medicine / Cancer / Cervical Cancer / UK hails high uptake of cervical cancer vaccine

UK hails high uptake of cervical cancer vaccine

January 31, 2011 By Jonathan 1 Comment

CMed Clinical Services

Published on 31/01/11 at 11:36am

The NHS campaign to vaccinate girls against the future risk of developing cervical cancer has been a success, according to government figures.

Over 84% of girls now aged 13-14 have received all three doses of GlaxoSmithKline’s Cervarix, which blocks the human papillomavirus (HPV).

Since HPV is the cause of 70% of cervical cancers, the immunisation programme – which began in September 2008 – should prevent up to 400 deaths a year, says public health minister Anne Milton.

More than four million doses of Cervarix have been given so far, with 76.4% of girls aged 12-13 having three doses in the second year of the programme.

In all, 60.4% of 12-19 year olds have had the full course, which the government says is twice as many as in the US. ‘Catch-up’ campaigns for girls aged 14-18 were introduced by the NHS in 2009.

“Being able to help protect young women against this disease is a fantastic development and the uptake is very encouraging,” said Milton.

“But we can always do more,” she added. “I would ask every girl between 12 and 18 who has not considered vaccination or who has not completed the full course to speak to their school or GP – all three doses are needed for full protection,” she added.

Health campaigners agreed. “It is encouraging to see that many girls are getting vaccinated against HPV but we would like to see this increase further,” said Robert Music, director of Jo’s Cervical Cancer Trust.

If uptake rises to 80% year on year, there could be a two-thirds reduction in cervical cancer incidence in women under 30 by 2025, the charity says.

In September 2008 Cervarix and its rival Gardasil, manufactured by Sanofi-Pasteur, were jointly awarded the prestigious UK Prix Galien award. Handed out biannually, the gong rewards innovative new drugs which represent the greatest advances in patient care.

But the NHS programme itself has been controversial on several grounds.

In the first instance, there was heated media discussion on the merit of vaccinating pre-pubescent girls against HPV, which can be transmitted through sexual contact.

And Cervarix, chosen by the government in a head-to-head pitch with Gardasil, does not offer the same protection as the Sanofi drug.

Cervarix and Gardasil are the only vaccines available to guard against HPV, but the latter also offers protection against genital warts – again caused by HPV.

Gardasil has been chosen by a number of countries for their own national vaccination campaigns, including France and Australia.

Critics criticised the (then Labour) government for what they saw as a missed opportunity to further protect young women.

Adam Hill

Read More…

Related

Filed Under: Cervical Cancer, Pharmaceuticals, STD's, Vaccine Marketing, Vaccine Politics/People Tagged With: Autoimmune Diseases, cervarix, Cervical Cancer HPV, Gardasil/Silgard, GlaxoSmithKline, HPV VACCINES, Merck, pharmaceuticals, STD's, vaccinations, Vaccine Adverse Reactions

Trackbacks

  1. Tweets that mention UK hails high uptake of cervical cancer vaccine | SaneVax General Blog -- Topsy.com says:
    February 1, 2011 at 3:07 am

    […] This post was mentioned on Twitter by SaneVax, SaneVax. SaneVax said: https://sanevax.org/blog/?p=1898 […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Nerea from Spain

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

protectasil drug ad parody

Protectasil (Gardasil) Drug Ad Parody

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2025 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in